The prognostic value of mutational status was nicely demonstrated in the study analyzing a series of 451 untreated primary localized GIST for KIT, PDGFRA and BRAF mutations finding that the mutational status is a significant prognostic indicator of overall survival (OS) [6]. The gene discussed is BRAF; the disease is gastrointestinal stromal tumor.